Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

e-Therapeutics Pulls in £16.6 million to Pursue Network Pharmacology Drug Discovery

This article was originally published in The Pink Sheet Daily

Executive Summary

AIM-listed e-Therapeutics has raised £16.6 million in a placing to pursue the promise of network pharmacology as a new drug discovery process

You may also be interested in...



e-Therapeutics Explores Network Pharmacology For Drug Discovery, Moves First Of Its Drugs Into Clinical Studies

The U.K. company e-Therapeutics outlines its novel "network pharmacology" approach for discovery R&D, its product pipeline, and collaboration plans as it moves its first product, with potential in cancer, into Phase I studies.

France's Pharnext Attracts Business Leaders As Investors; Uses Network Pharmacology For New Low-Dose Combos

French industrialists invest in a Series B fundraising for Pharnext, attracted by its network pharmacology approach to neurological and other diseases.

France's Pharnext Attracts Business Leaders As Investors; Uses Network Pharmacology For New Low-Dose Combos

French industrialists invest in a Series B fundraising for Pharnext, attracted by its network pharmacology approach to neurological and other diseases.

Topics

UsernamePublicRestriction

Register

PS071844

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel